Suppr超能文献

肝切除或消融患者症状体验的评估。

Assessment of symptom experience in patients undergoing hepatic resection or ablation.

作者信息

Eid Sebastian, Stromberg Arnold J, Ames Susan, Ellis Susan, McMasters Kelly M, Martin Robert C G

机构信息

Department of Surgery, Division of Surgical Oncology, University of Louisville School of Medicine, James Graham Brown Cancer Center, Louisville, Kentucky, USA.

出版信息

Cancer. 2006 Dec 1;107(11):2715-22. doi: 10.1002/cncr.22297.

Abstract

BACKGROUND

Quality of life (QOL) currently is considered both clinically meaningful and biologically important for patient outcome and is considered as important as disease-free and overall survival. Thus, the objective of the current study was to evaluate the QOL symptoms of patients who underwent major hepatic resection, minor hepatic resection, and ablation for primary or metastatic cancer to the liver.

METHODS

From October 2002 to June 2004, 40 patients who underwent either hepatic ablation or resection were enrolled. Patients were assessed at 5 time points (the initial visit, the initial postoperative visit, and visits at 6 weeks, 3 months, and 6 months) by questionnaires of the Functional Assessment in Cancer Therapy (FACT) core instrument with the Hepatobiliary subscale (FACT-Hep), the FACT Hepatobiliary Symptom Index (FHSI-8), the Profile of Mood States (POMS), the European Organization for Research and Treatment of Cancer (EORTC) QOL questionnaire (QLQ) for patients with pancreatic cancer (QLQ-PAN), and the general core EORTC QLQ.

RESULTS

The patients enrolled included 20 men and 20 women with a median age of 62 years (range, 41-77 years), including 24 patients who underwent major hepatectomy, 8 patients who underwent minor hepatectomy, and 8 patients who underwent ablation. An evaluation of the FACT Physical, Social, Emotional, and Functional subscales demonstrated no differences at the initial or first postoperative visits. However, at 6 weeks, both the Physical (P = .0455) and Functional (P = .0372) scores were significantly worse for the major hepatectomy group. At 3 months, all QOL parameters were similar. Similar differences were observed at 6 weeks for the FHSI-8 (P = .02), POMS (P = .007), QLQ-PAN (P = .04), and EORTC (P = .003) with the resolution of this difference at 3 months.

CONCLUSIONS

There was little difference in QOL between patients who underwent major hepatic resection, minor hepatic resection, and hepatic ablation. Patients who underwent major hepatectomy demonstrated a worse QOL at 6 weeks compared with patients who underwent minor hepatic resection and hepatic ablation, with the resolution of this difference and significant improvements observed in all 3 groups at 3 months.

摘要

背景

目前,生活质量(QOL)在临床意义和生物学重要性方面均被认为对患者预后具有重要意义,且与无病生存期和总生存期同样重要。因此,本研究的目的是评估接受肝大部切除术、肝小部切除术以及针对原发性或转移性肝癌进行消融治疗的患者的生活质量症状。

方法

从2002年10月至2004年6月,纳入40例接受肝消融或肝切除术的患者。通过癌症治疗功能评估(FACT)核心量表的问卷调查对患者在5个时间点(初次就诊、术后初次就诊以及6周、3个月和6个月时的就诊)进行评估,该问卷包括肝胆亚量表(FACT-Hep)、FACT肝胆症状指数(FHSI-8)、情绪状态量表(POMS)、欧洲癌症研究与治疗组织(EORTC)针对胰腺癌患者的生活质量问卷(QLQ)(QLQ-PAN)以及EORTC通用核心问卷。

结果

纳入的患者包括20名男性和20名女性,中位年龄为62岁(范围41 - 77岁),其中24例接受肝大部切除术,8例接受肝小部切除术,8例接受消融治疗。对FACT身体、社会、情感和功能亚量表的评估显示,在初次或术后初次就诊时无差异。然而,在6周时,肝大部切除术组的身体(P = .0455)和功能(P = .0372)得分明显更差。在3个月时,所有生活质量参数相似。在6周时,FHSI-8(P = .02)、POMS(P = .007)、QLQ-PAN(P = .04)和EORTC(P = .003)也观察到类似差异,且在3个月时这种差异消失。

结论

接受肝大部切除术、肝小部切除术和肝消融治疗的患者在生活质量方面差异不大。与接受肝小部切除术和肝消融治疗的患者相比,接受肝大部切除术的患者在6周时生活质量较差,但在3个月时这种差异消失,且所有3组均有显著改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验